VHL pathogenic variants

Biomarker type: Germline variant

Gene context: VHL

Chromosome: 3

Requires pathogenic: True

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (1)	VHL pathogenic variants	Renal Cell Carcinoma	Belzutifan
FDA (1)	VHL pathogenic variants	Central Nervous System Hemangioblastoma	Belzutifan
FDA (1)	VHL pathogenic variants	Pancreatic Neuroendocrine Tumor	Belzutifan